Maria Sklodowska-curie National Research Institute Of Oncology
Clinical trials sponsored by Maria Sklodowska-curie National Research Institute Of Oncology, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Do surgical glues really prevent brain fluid leaks? new trial aims to find out Results expected Dec 2026 (estimated)
-
Triple therapy shows promise in shrinking sarcomas before surgery
Disease control OngoingThis study tests whether combining an immunotherapy drug (pembrolizumab) with another immune-boosting protein (eftilagimod alpha) and radiation therapy can shrink soft tissue sarcomas before surgery. About 40 adults with high-risk, non-spread sarcomas will receive this combinatio…
Phase 2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Heart shield: diabetes drug may prevent Chemo-Induced cardiac damage
Prevention OngoingThis study tests whether empagliflozin, a drug used for diabetes, can prevent heart damage in cancer patients receiving strong chemotherapy (anthracyclines). About 220 adults with cancer but no prior heart failure will take either the drug or a placebo daily for 12 months. The go…
Phase 3 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC